Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Silberstein

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicityM E Rothenberg, J Petersen, R L Stevens, et al.
The Journal of Clinical Investigation|June 1, 1988
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3M E Rothenberg, W F Owen, D S Silberstein, et al.
Archives of Neurology|December 1, 1992
Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research GroupN T Mathew, J Dexter, J Couch, et al.
The Journal of Experimental Medicine|July 1, 1987
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblastsW F Owen, M E Rothenberg, D S Silberstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989
Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cellsD S Silberstein, D D Schoof, M L Rodrick, et al.
Headache|March 27, 2001
Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyL Newman, L K Mannix, S Landy, et al.
Headache|September 29, 2001
Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraineE Loder, J L Brandes, S Silberstein, et al.
Neurology|June 12, 2002
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxisFrederick G Freitag, S D Collins, H A Carlson, et al.
Neurology|September 25, 1998
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study GroupM S Kramer, D Matzura-Wolfe, A Polis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factorD S Silberstein, W F Owen, J C Gasson, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicityM E Rothenberg, J Petersen, R L Stevens, et al.
The Journal of Clinical Investigation|June 1, 1988
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3M E Rothenberg, W F Owen, D S Silberstein, et al.
Archives of Neurology|December 1, 1992
Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research GroupN T Mathew, J Dexter, J Couch, et al.
The Journal of Experimental Medicine|July 1, 1987
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblastsW F Owen, M E Rothenberg, D S Silberstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989
Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cellsD S Silberstein, D D Schoof, M L Rodrick, et al.
Headache|March 27, 2001
Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyL Newman, L K Mannix, S Landy, et al.
Headache|September 29, 2001
Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraineE Loder, J L Brandes, S Silberstein, et al.
Neurology|June 12, 2002
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxisFrederick G Freitag, S D Collins, H A Carlson, et al.
Neurology|September 25, 1998
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study GroupM S Kramer, D Matzura-Wolfe, A Polis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factorD S Silberstein, W F Owen, J C Gasson, et al.
Pageof 8